Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

username:

paswword:

Welcome to visit our booth at CPHI Milan 2007

Welcome to visit us during CPHI-SHANGHAI2008 at our booth: 4F32.

We will participate CPHI-SHANGHAI2008 during June 24-26 which hold in Shanghai, You are warmly invited to visit us. Looking forward to seeing you at our booth: 4F32.

	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: 4F32.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: C36.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: CP51083.
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Mr. Zhang Weizhong, the General Manager of Jinhe Bio-tec is entitled as “Science and Technology Hero”.
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	Mr. Zhang Weizhong wins the prize of “Shanghai Excellent Entrepreneur for Invention Implement”.
	A new patent of Jinhe Bio-Tec called “a new method of Docetaxel synthesis” was published.